Rejected at 4:35 p.m. Mar, 20, 2024 ] by Ahmed7
Author: ray010
Related Note: 1504733615907
Rationale for change

I am under the impression that the xanthine oxidase inhibitors (allopurinol, febuxostat) are the first-line drugs for the treatment of chronic gout, not probenecid and pegloticase. AMBOSS supports that rationale as well.

Rejection reason

please see this nid:1496873123942

underexcretors vs overproducers is the main delineator here

Please resubmit with an acceptable source. Please review suggestion guidelines, specifically rule #1: https://community.ankihub.net/t/anking-step-deck-submission-guidelines/166504

Text Text
Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Bootcamp
OME
Additional Resources
Empty field
One by one
Empty field
#AK_Step1_v12::#FirstAid::11_Musculoskeletal_Skin_and_Connective_Tissue::04_Pharm::09_Gout_drugs #AK_Step1_v12::#Pixorize::^Missing_image #AK_Step1_v12::#FirstAid::11_Musculoskeletal_Skin_and_Connective_Tissue::04_Pharm::09_Gout_drugs::01_Chronic_gout_drugs_(preventive)::*Pegloticase_Rasburicase #AK_Other::!AK_UpdateTags::AnKing_Image::!Subjects::Nephrology_&_Urology::Gout_Drugs #AK_Step1_v12::#FirstAid::01_Biochem::01_Molecular::04_Purine_salvage_deficiencies::02_Lesch-Nyhan_syndrome::*Probenecid #AK_Step1_v12::#OME::PreClinical::Musculoskeletal #AK_Step2_v12::#B&B::09_MSK::01_General::03_Gout::Extra #AK_Other::!AK_UpdateTags::AnKing_Image::Aiman::Gout_Drugs #AK_Step1_v12::#Bootcamp::Musculoskeletal::15_Pharmacology::05_Gout_Medications #AK_Step2_v12::#SketchyIM::07_Rheumatology::02_Crystalline_Disorders::01_Gout_&_Pseudogout_SOAP #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step1_v12::#Pixorize::03_Pharmacology::13_Musculoskeletal_Pharm::14_Probenecid #AK_Step1_v12::#Physeo::09_Pharm::09_Musculoskeletal::08_Acute_and_Chronic_Gout_Treatment #PANCE::EOR::IM #AK_Other::#AK_Original_Decks::Step_1::Lolnotacop::Drugs #AK_Step1_v12::#Low/HighYield::3-HighYield-temporary #AK_Step1_v12::#SketchyPharm::03_Blood_&_Inflammation::03_Anti-inflammatory::02_Gout_drugs